SLAM Ortho selected for Texas Medical Center BioBridge

June 26th, 2026,

SLAM Ortho has been selected, alongside 11 other Dutch medtech companies, to take part in the BioBridge program between the Netherlands and the Texas Medical Center.

For medtech companies looking to grow in the United States, thorough preparation is essential - clinical validation, reimbursement, market access, and building the right partnerships all need to be in place before making the move.

The program is a joint initiative of the Texas Medical Center, Invest International, the Netherlands Enterprise Agency (RVO), Health~Holland, Task Force Health Care (TFHC), ROM Nederland, InnovationQuarter, NBSO Texas, and the regional development agencies.

Through this program, we gain direct access to the Texas Medical Center in Houston - a great opportunity to build the right connections and shape our US market entry strategy.